 | • レポートコード：D0GIR-02989 • 出版社/出版日：GlobalInfoResearch / 2020年9月30日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、124ページ • 納品方法：Eメール • 産業分類：New Technology |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、COVID-19用特定抗ウイルス薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。COVID-19用特定抗ウイルス薬の種類別市場規模（タブレット、注射）、用途別市場規模（軽症患者、重症患者）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Sanofi、Advanz Pharma、Teva、Novartis、Apotex、Shanghai Zhongxisanwei、Kyung Poong、Mylan、Zydus Cadila、Sun Pharma、Rising Pharmaceutical、Guangzhou Baiyunshan Guanghua Pharmaceutical、Ipca Laboratories、KPC Group、Shanghai Pharma、Bayer、Hanlim Pharmaceutical、CSPC Group、Sichuan Sunny Hope、Bristol Laboratories、Jinghua Pharmaceutical Group、Zhongsheng Pharma、North China Pharmaceutical Group ・地域別グローバル市場分析 2015年-2020年 ・COVID-19用特定抗ウイルス薬の北米市場（アメリカ、カナダ、メキシコ） ・COVID-19用特定抗ウイルス薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・COVID-19用特定抗ウイルス薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・COVID-19用特定抗ウイルス薬の南米市場（ブラジル、アルゼンチン） ・COVID-19用特定抗ウイルス薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：タブレット、注射 ・用途別分析：軽症患者、重症患者 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The Specific Antiviral Drugs for COVID-19 market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global Specific Antiviral Drugs for COVID-19 sales will be xx in 2020 from Specific Antiviral Drugs for COVID-19 million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Specific Antiviral Drugs for COVID-19 market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the Specific Antiviral Drugs for COVID-19 industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Specific Antiviral Drugs for COVID-19 and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
Specific Antiviral Drugs for COVID-19 market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Specific Antiviral Drugs for COVID-19 market has been segmented into:
Tablet
Injection
By Application, Specific Antiviral Drugs for COVID-19 has been segmented into:
Mild Symptom Patient
Critically Ill Patient
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Specific Antiviral Drugs for COVID-19 market presented in the report. This section sheds light on the sales growth of different regional and country-level Specific Antiviral Drugs for COVID-19 markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Specific Antiviral Drugs for COVID-19 market.
The report offers in-depth assessment of the growth and other aspects of the Specific Antiviral Drugs for COVID-19 market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Specific Antiviral Drugs for COVID-19 Market Share Analysis
Specific Antiviral Drugs for COVID-19 competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Specific Antiviral Drugs for COVID-19 sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Specific Antiviral Drugs for COVID-19 sales, revenue and market share for each player covered in this report.
The major players covered in Specific Antiviral Drugs for COVID-19 are:
Sanofi
Advanz Pharma
Teva
Novartis
Apotex
Shanghai Zhongxisanwei
Kyung Poong
Mylan
Zydus Cadila
Sun Pharma
Rising Pharmaceutical
Guangzhou Baiyunshan Guanghua Pharmaceutical
Ipca Laboratories
KPC Group
Shanghai Pharma
Bayer
Hanlim Pharmaceutical
CSPC Group
Sichuan Sunny Hope
Bristol Laboratories
Jinghua Pharmaceutical Group
Zhongsheng Pharma
North China Pharmaceutical Group
Among other players domestic and global, Specific Antiviral Drugs for COVID-19 market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 Specific Antiviral Drugs for COVID-19 Market Overview
1.1 Product Overview and Scope of Specific Antiviral Drugs for COVID-19
1.2 Classification of Specific Antiviral Drugs for COVID-19 by Type
1.2.1 Global Specific Antiviral Drugs for COVID-19 Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Specific Antiviral Drugs for COVID-19 Revenue Market Share by Type in 2019
1.2.3 Tablet
1.2.4 Injection
1.3 Global Specific Antiviral Drugs for COVID-19 Market by Application
1.3.1 Overview: Global Specific Antiviral Drugs for COVID-19 Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Mild Symptom Patient
1.3.3 Critically Ill Patient
1.4 Global Specific Antiviral Drugs for COVID-19 Market by Regions
1.4.1 Global Specific Antiviral Drugs for COVID-19 Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Specific Antiviral Drugs for COVID-19 (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Specific Antiviral Drugs for COVID-19 Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Specific Antiviral Drugs for COVID-19 Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Specific Antiviral Drugs for COVID-19 Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Specific Antiviral Drugs for COVID-19 Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Specific Antiviral Drugs for COVID-19 Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: Specific Antiviral Drugs for COVID-19 Industry Impact
1.5.1 COVID-19 Potential Implications for the Specific Antiviral Drugs for COVID-19
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Specific Antiviral Drugs for COVID-19
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Sanofi
2.1.1 Sanofi Details
2.1.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Sanofi SWOT Analysis
2.1.4 Sanofi Product and Services
2.1.5 Sanofi Specific Antiviral Drugs for COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.2 Advanz Pharma
2.2.1 Advanz Pharma Details
2.2.2 Advanz Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Advanz Pharma SWOT Analysis
2.2.4 Advanz Pharma Product and Services
2.2.5 Advanz Pharma Specific Antiviral Drugs for COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.3 Teva
2.3.1 Teva Details
2.3.2 Teva Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Teva SWOT Analysis
2.3.4 Teva Product and Services
2.3.5 Teva Specific Antiviral Drugs for COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.4 Novartis
2.4.1 Novartis Details
2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Novartis SWOT Analysis
2.4.4 Novartis Product and Services
2.4.5 Novartis Specific Antiviral Drugs for COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.5 Apotex
2.5.1 Apotex Details
2.5.2 Apotex Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Apotex SWOT Analysis
2.5.4 Apotex Product and Services
2.5.5 Apotex Specific Antiviral Drugs for COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.6 Shanghai Zhongxisanwei
2.6.1 Shanghai Zhongxisanwei Details
2.6.2 Shanghai Zhongxisanwei Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Shanghai Zhongxisanwei SWOT Analysis
2.6.4 Shanghai Zhongxisanwei Product and Services
2.6.5 Shanghai Zhongxisanwei Specific Antiviral Drugs for COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.7 Kyung Poong
2.7.1 Kyung Poong Details
2.7.2 Kyung Poong Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Kyung Poong SWOT Analysis
2.7.4 Kyung Poong Product and Services
2.7.5 Kyung Poong Specific Antiviral Drugs for COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.8 Mylan
2.8.1 Mylan Details
2.8.2 Mylan Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Mylan SWOT Analysis
2.8.4 Mylan Product and Services
2.8.5 Mylan Specific Antiviral Drugs for COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.9 Zydus Cadila
2.9.1 Zydus Cadila Details
2.9.2 Zydus Cadila Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Zydus Cadila SWOT Analysis
2.9.4 Zydus Cadila Product and Services
2.9.5 Zydus Cadila Specific Antiviral Drugs for COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.10 Sun Pharma
2.10.1 Sun Pharma Details
2.10.2 Sun Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Sun Pharma SWOT Analysis
2.10.4 Sun Pharma Product and Services
2.10.5 Sun Pharma Specific Antiviral Drugs for COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.11 Rising Pharmaceutical
2.11.1 Rising Pharmaceutical Details
2.11.2 Rising Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Rising Pharmaceutical SWOT Analysis
2.11.4 Rising Pharmaceutical Product and Services
2.11.5 Rising Pharmaceutical Specific Antiviral Drugs for COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.12 Guangzhou Baiyunshan Guanghua Pharmaceutical
2.12.1 Guangzhou Baiyunshan Guanghua Pharmaceutical Details
2.12.2 Guangzhou Baiyunshan Guanghua Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 Guangzhou Baiyunshan Guanghua Pharmaceutical SWOT Analysis
2.12.4 Guangzhou Baiyunshan Guanghua Pharmaceutical Product and Services
2.12.5 Guangzhou Baiyunshan Guanghua Pharmaceutical Specific Antiviral Drugs for COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.13 Ipca Laboratories
2.13.1 Ipca Laboratories Details
2.13.2 Ipca Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Ipca Laboratories SWOT Analysis
2.13.4 Ipca Laboratories Product and Services
2.13.5 Ipca Laboratories Specific Antiviral Drugs for COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.14 KPC Group
2.14.1 KPC Group Details
2.14.2 KPC Group Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 KPC Group SWOT Analysis
2.14.4 KPC Group Product and Services
2.14.5 KPC Group Specific Antiviral Drugs for COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.15 Shanghai Pharma
2.15.1 Shanghai Pharma Details
2.15.2 Shanghai Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 Shanghai Pharma SWOT Analysis
2.15.4 Shanghai Pharma Product and Services
2.15.5 Shanghai Pharma Specific Antiviral Drugs for COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.16 Bayer
2.16.1 Bayer Details
2.16.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.16.3 Bayer SWOT Analysis
2.16.4 Bayer Product and Services
2.16.5 Bayer Specific Antiviral Drugs for COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.17 Hanlim Pharmaceutical
2.17.1 Hanlim Pharmaceutical Details
2.17.2 Hanlim Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.17.3 Hanlim Pharmaceutical SWOT Analysis
2.17.4 Hanlim Pharmaceutical Product and Services
2.17.5 Hanlim Pharmaceutical Specific Antiviral Drugs for COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.18 CSPC Group
2.18.1 CSPC Group Details
2.18.2 CSPC Group Major Business and Total Revenue (Financial Highlights) Analysis
2.18.3 CSPC Group SWOT Analysis
2.18.4 CSPC Group Product and Services
2.18.3 CSPC Group Specific Antiviral Drugs for COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.19 Sichuan Sunny Hope
2.19.1 Sichuan Sunny Hope Details
2.19.2 Sichuan Sunny Hope Major Business and Total Revenue (Financial Highlights) Analysis
2.19.3 Sichuan Sunny Hope SWOT Analysis
2.19.4 Sichuan Sunny Hope Product and Services
2.19.5 Sichuan Sunny Hope Specific Antiviral Drugs for COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.20 Bristol Laboratories
2.20.1 Bristol Laboratories Details
2.20.2 Bristol Laboratories Major Business and Total Revenue (Financial Highlights) Analysis
2.20.3 Bristol Laboratories SWOT Analysis
2.20.4 Bristol Laboratories Product and Services
2.20.5 Bristol Laboratories Specific Antiviral Drugs for COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.21 Jinghua Pharmaceutical Group
2.21.1 Jinghua Pharmaceutical Group Details
2.21.2 Jinghua Pharmaceutical Group Major Business and Total Revenue (Financial Highlights) Analysis
2.21.3 Jinghua Pharmaceutical Group SWOT Analysis
2.21.4 Jinghua Pharmaceutical Group Product and Services
2.21.5 Jinghua Pharmaceutical Group Specific Antiviral Drugs for COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.22 Zhongsheng Pharma
2.22.1 Zhongsheng Pharma Details
2.22.2 Zhongsheng Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.22.3 Zhongsheng Pharma SWOT Analysis
2.22.4 Zhongsheng Pharma Product and Services
2.22.5 Zhongsheng Pharma Specific Antiviral Drugs for COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
2.23 North China Pharmaceutical Group
2.23.1 North China Pharmaceutical Group Details
2.23.2 North China Pharmaceutical Group Major Business and Total Revenue (Financial Highlights) Analysis
2.23.3 North China Pharmaceutical Group SWOT Analysis
2.23.4 North China Pharmaceutical Group Product and Services
2.23.5 North China Pharmaceutical Group Specific Antiviral Drugs for COVID-19 Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Specific Antiviral Drugs for COVID-19 Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Specific Antiviral Drugs for COVID-19 Players Market Share
3.2.2 Top 10 Specific Antiviral Drugs for COVID-19 Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Specific Antiviral Drugs for COVID-19 Revenue and Market Share by Regions
4.2 North America Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
4.3 Europe Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
4.5 South America Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
5 North America Specific Antiviral Drugs for COVID-19 Revenue by Countries
5.1 North America Specific Antiviral Drugs for COVID-19 Revenue by Countries (2015-2020)
5.2 USA Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
5.3 Canada Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
5.4 Mexico Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
6 Europe Specific Antiviral Drugs for COVID-19 Revenue by Countries
6.1 Europe Specific Antiviral Drugs for COVID-19 Revenue by Countries (2015-2020)
6.2 Germany Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
6.3 UK Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
6.4 France Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
6.5 Russia Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
6.6 Italy Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Specific Antiviral Drugs for COVID-19 Revenue by Countries
7.1 Asia-Pacific Specific Antiviral Drugs for COVID-19 Revenue by Countries (2015-2020)
7.2 China Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
7.3 Japan Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
7.4 Korea Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
7.5 India Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
8 South America Specific Antiviral Drugs for COVID-19 Revenue by Countries
8.1 South America Specific Antiviral Drugs for COVID-19 Revenue by Countries (2015-2020)
8.2 Brazil Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
8.3 Argentina Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Specific Antiviral Drugs for COVID-19 by Countries
9.1 Middle East & Africa Specific Antiviral Drugs for COVID-19 Revenue by Countries (2015-2020)
9.2 Saudi Arabia Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
9.3 UAE Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
9.4 Egypt Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
9.5 South Africa Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Specific Antiviral Drugs for COVID-19 Revenue and Market Share by Type (2015-2020)
10.2 Global Specific Antiviral Drugs for COVID-19 Market Forecast by Type (2019-2024)
10.3 Tablet Revenue Growth Rate (2015-2025)
10.4 Injection Revenue Growth Rate (2015-2025)
11 Global Specific Antiviral Drugs for COVID-19 Market Segment by Application
11.1 Global Specific Antiviral Drugs for COVID-19 Revenue Market Share by Application (2015-2020)
11.2 Specific Antiviral Drugs for COVID-19 Market Forecast by Application (2019-2024)
11.3 Mild Symptom Patient Revenue Growth (2015-2020)
11.4 Critically Ill Patient Revenue Growth (2015-2020)
12 Global Specific Antiviral Drugs for COVID-19 Market Size Forecast (2021-2025)
12.1 Global Specific Antiviral Drugs for COVID-19 Market Size Forecast (2021-2025)
12.2 Global Specific Antiviral Drugs for COVID-19 Market Forecast by Regions (2021-2025)
12.3 North America Specific Antiviral Drugs for COVID-19 Revenue Market Forecast (2021-2025)
12.4 Europe Specific Antiviral Drugs for COVID-19 Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Specific Antiviral Drugs for COVID-19 Revenue Market Forecast (2021-2025)
12.6 South America Specific Antiviral Drugs for COVID-19 Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Specific Antiviral Drugs for COVID-19 Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Specific Antiviral Drugs for COVID-19 Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Specific Antiviral Drugs for COVID-19 by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Specific Antiviral Drugs for COVID-19 Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Specific Antiviral Drugs for COVID-19 Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global Specific Antiviral Drugs for COVID-19 Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Sanofi Corporate Information, Location and Competitors
Table 7. Sanofi Specific Antiviral Drugs for COVID-19 Major Business
Table 8. Sanofi Specific Antiviral Drugs for COVID-19 Total Revenue (USD Million) (2017-2018)
Table 9. Sanofi SWOT Analysis
Table 10. Sanofi Specific Antiviral Drugs for COVID-19 Product and Solutions
Table 11. Sanofi Specific Antiviral Drugs for COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Advanz Pharma Corporate Information, Location and Competitors
Table 13. Advanz Pharma Specific Antiviral Drugs for COVID-19 Major Business
Table 14. Advanz Pharma Specific Antiviral Drugs for COVID-19 Total Revenue (USD Million) (2018-2019)
Table 15. Advanz Pharma SWOT Analysis
Table 16. Advanz Pharma Specific Antiviral Drugs for COVID-19 Product and Solutions
Table 17. Advanz Pharma Specific Antiviral Drugs for COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. Teva Corporate Information, Location and Competitors
Table 19. Teva Specific Antiviral Drugs for COVID-19 Major Business
Table 20. Teva Specific Antiviral Drugs for COVID-19 Total Revenue (USD Million) (2017-2018)
Table 21. Teva SWOT Analysis
Table 22. Teva Specific Antiviral Drugs for COVID-19 Product and Solutions
Table 23. Teva Specific Antiviral Drugs for COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Novartis Corporate Information, Location and Competitors
Table 25. Novartis Specific Antiviral Drugs for COVID-19 Major Business
Table 26. Novartis Specific Antiviral Drugs for COVID-19 Total Revenue (USD Million) (2017-2018)
Table 27. Novartis SWOT Analysis
Table 28. Novartis Specific Antiviral Drugs for COVID-19 Product and Solutions
Table 29. Novartis Specific Antiviral Drugs for COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. Apotex Corporate Information, Location and Competitors
Table 31. Apotex Specific Antiviral Drugs for COVID-19 Major Business
Table 32. Apotex Specific Antiviral Drugs for COVID-19 Total Revenue (USD Million) (2017-2018)
Table 33. Apotex SWOT Analysis
Table 34. Apotex Specific Antiviral Drugs for COVID-19 Product and Solutions
Table 35. Apotex Specific Antiviral Drugs for COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Shanghai Zhongxisanwei Corporate Information, Location and Competitors
Table 37. Shanghai Zhongxisanwei Specific Antiviral Drugs for COVID-19 Major Business
Table 38. Shanghai Zhongxisanwei Specific Antiviral Drugs for COVID-19 Total Revenue (USD Million) (2017-2018)
Table 39. Shanghai Zhongxisanwei SWOT Analysis
Table 40. Shanghai Zhongxisanwei Specific Antiviral Drugs for COVID-19 Product and Solutions
Table 41. Shanghai Zhongxisanwei Specific Antiviral Drugs for COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Kyung Poong Corporate Information, Location and Competitors
Table 43. Kyung Poong Specific Antiviral Drugs for COVID-19 Major Business
Table 44. Kyung Poong Specific Antiviral Drugs for COVID-19 Total Revenue (USD Million) (2017-2018)
Table 45. Kyung Poong SWOT Analysis
Table 46. Kyung Poong Specific Antiviral Drugs for COVID-19 Product and Solutions
Table 47. Kyung Poong Specific Antiviral Drugs for COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 48. Mylan Corporate Information, Location and Competitors
Table 49. Mylan Specific Antiviral Drugs for COVID-19 Major Business
Table 50. Mylan Specific Antiviral Drugs for COVID-19 Total Revenue (USD Million) (2017-2018)
Table 51. Mylan SWOT Analysis
Table 52. Mylan Specific Antiviral Drugs for COVID-19 Product and Solutions
Table 53. Mylan Specific Antiviral Drugs for COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 54. Zydus Cadila Corporate Information, Location and Competitors
Table 55. Zydus Cadila Specific Antiviral Drugs for COVID-19 Major Business
Table 56. Zydus Cadila Specific Antiviral Drugs for COVID-19 Total Revenue (USD Million) (2017-2018)
Table 57. Zydus Cadila SWOT Analysis
Table 58. Zydus Cadila Specific Antiviral Drugs for COVID-19 Product and Solutions
Table 59. Zydus Cadila Specific Antiviral Drugs for COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 60. Sun Pharma Corporate Information, Location and Competitors
Table 61. Sun Pharma Specific Antiviral Drugs for COVID-19 Major Business
Table 62. Sun Pharma Specific Antiviral Drugs for COVID-19 Total Revenue (USD Million) (2017-2018)
Table 63. Sun Pharma SWOT Analysis
Table 64. Sun Pharma Specific Antiviral Drugs for COVID-19 Product and Solutions
Table 65. Sun Pharma Specific Antiviral Drugs for COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 66. Rising Pharmaceutical Corporate Information, Location and Competitors
Table 67. Rising Pharmaceutical Specific Antiviral Drugs for COVID-19 Major Business
Table 68. Rising Pharmaceutical Specific Antiviral Drugs for COVID-19 Total Revenue (USD Million) (2017-2018)
Table 69. Rising Pharmaceutical SWOT Analysis
Table 70. Rising Pharmaceutical Specific Antiviral Drugs for COVID-19 Product and Solutions
Table 71. Rising Pharmaceutical Specific Antiviral Drugs for COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 72. Guangzhou Baiyunshan Guanghua Pharmaceutical Corporate Information, Location and Competitors
Table 73. Guangzhou Baiyunshan Guanghua Pharmaceutical Specific Antiviral Drugs for COVID-19 Major Business
Table 74. Guangzhou Baiyunshan Guanghua Pharmaceutical Specific Antiviral Drugs for COVID-19 Total Revenue (USD Million) (2017-2018)
Table 75. Guangzhou Baiyunshan Guanghua Pharmaceutical SWOT Analysis
Table 76. Guangzhou Baiyunshan Guanghua Pharmaceutical Specific Antiviral Drugs for COVID-19 Product and Solutions
Table 77. Guangzhou Baiyunshan Guanghua Pharmaceutical Specific Antiviral Drugs for COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 78. Ipca Laboratories Corporate Information, Location and Competitors
Table 79. Ipca Laboratories Specific Antiviral Drugs for COVID-19 Major Business
Table 80. Ipca Laboratories Specific Antiviral Drugs for COVID-19 Total Revenue (USD Million) (2017-2018)
Table 81. Ipca Laboratories SWOT Analysis
Table 82. Ipca Laboratories Specific Antiviral Drugs for COVID-19 Product and Solutions
Table 83. Ipca Laboratories Specific Antiviral Drugs for COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 84. KPC Group Corporate Information, Location and Competitors
Table 85. KPC Group Specific Antiviral Drugs for COVID-19 Major Business
Table 86. KPC Group Specific Antiviral Drugs for COVID-19 Total Revenue (USD Million) (2017-2018)
Table 87. KPC Group SWOT Analysis
Table 88. KPC Group Specific Antiviral Drugs for COVID-19 Product and Solutions
Table 89. KPC Group Specific Antiviral Drugs for COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 90. Shanghai Pharma Corporate Information, Location and Competitors
Table 91. Shanghai Pharma Specific Antiviral Drugs for COVID-19 Major Business
Table 92. Shanghai Pharma Specific Antiviral Drugs for COVID-19 Total Revenue (USD Million) (2017-2018)
Table 93. Shanghai Pharma SWOT Analysis
Table 94. Shanghai Pharma Specific Antiviral Drugs for COVID-19 Product and Solutions
Table 95. Shanghai Pharma Specific Antiviral Drugs for COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 96. Bayer Corporate Information, Location and Competitors
Table 97. Bayer Specific Antiviral Drugs for COVID-19 Major Business
Table 98. Bayer Specific Antiviral Drugs for COVID-19 Total Revenue (USD Million) (2017-2018)
Table 99. Bayer SWOT Analysis
Table 100. Bayer Specific Antiviral Drugs for COVID-19 Product and Solutions
Table 101. Bayer Specific Antiviral Drugs for COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 102. Hanlim Pharmaceutical Corporate Information, Location and Competitors
Table 103. Hanlim Pharmaceutical Specific Antiviral Drugs for COVID-19 Major Business
Table 104. Hanlim Pharmaceutical Specific Antiviral Drugs for COVID-19 Total Revenue (USD Million) (2017-2018)
Table 105. Hanlim Pharmaceutical SWOT Analysis
Table 106. Hanlim Pharmaceutical Specific Antiviral Drugs for COVID-19 Product and Solutions
Table 107. Hanlim Pharmaceutical Specific Antiviral Drugs for COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 108. CSPC Group Specific Antiviral Drugs for COVID-19 Type and Application
Table 109. CSPC Group Specific Antiviral Drugs for COVID-19 Major Business
Table 110. CSPC Group Specific Antiviral Drugs for COVID-19 Total Revenue (USD Million) (2017-2018)
Table 111. CSPC Group SWOT Analysis
Table 112. CSPC Group Specific Antiviral Drugs for COVID-19 Product and Solutions
Table 113. CSPC Group Specific Antiviral Drugs for COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 114. Sichuan Sunny Hope Corporate Information, Location and Competitors
Table 115. Sichuan Sunny Hope Specific Antiviral Drugs for COVID-19 Major Business
Table 116. Sichuan Sunny Hope Specific Antiviral Drugs for COVID-19 Total Revenue (USD Million) (2017-2018)
Table 117. Sichuan Sunny Hope SWOT Analysis
Table 118. Sichuan Sunny Hope Specific Antiviral Drugs for COVID-19 Product and Solutions
Table 119. Sichuan Sunny Hope Specific Antiviral Drugs for COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 120. Bristol Laboratories Corporate Information, Location and Competitors
Table 121. Bristol Laboratories Specific Antiviral Drugs for COVID-19 Major Business
Table 122. Bristol Laboratories Specific Antiviral Drugs for COVID-19 Total Revenue (USD Million) (2017-2018)
Table 123. Bristol Laboratories SWOT Analysis
Table 124. Bristol Laboratories Specific Antiviral Drugs for COVID-19 Product and Solutions
Table 125. Bristol Laboratories Specific Antiviral Drugs for COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 126. Jinghua Pharmaceutical Group Corporate Information, Location and Competitors
Table 127. Jinghua Pharmaceutical Group Specific Antiviral Drugs for COVID-19 Major Business
Table 128. Jinghua Pharmaceutical Group Specific Antiviral Drugs for COVID-19 Total Revenue (USD Million) (2017-2018)
Table 129. Jinghua Pharmaceutical Group SWOT Analysis
Table 130. Jinghua Pharmaceutical Group Specific Antiviral Drugs for COVID-19 Product and Solutions
Table 131. Jinghua Pharmaceutical Group Specific Antiviral Drugs for COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 132. Zhongsheng Pharma Corporate Information, Location and Competitors
Table 133. Zhongsheng Pharma Specific Antiviral Drugs for COVID-19 Major Business
Table 134. Zhongsheng Pharma Specific Antiviral Drugs for COVID-19 Total Revenue (USD Million) (2017-2018)
Table 135. Zhongsheng Pharma SWOT Analysis
Table 136. Zhongsheng Pharma Specific Antiviral Drugs for COVID-19 Product and Solutions
Table 137. Zhongsheng Pharma Specific Antiviral Drugs for COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 138. North China Pharmaceutical Group Corporate Information, Location and Competitors
Table 139. North China Pharmaceutical Group Specific Antiviral Drugs for COVID-19 Major Business
Table 140. North China Pharmaceutical Group Specific Antiviral Drugs for COVID-19 Total Revenue (USD Million) (2017-2018)
Table 141. North China Pharmaceutical Group SWOT Analysis
Table 142. North China Pharmaceutical Group Specific Antiviral Drugs for COVID-19 Product and Solutions
Table 143. North China Pharmaceutical Group Specific Antiviral Drugs for COVID-19 Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 144. Global Specific Antiviral Drugs for COVID-19 Revenue (Million USD) by Players (2015-2020)
Table 145. Global Specific Antiviral Drugs for COVID-19 Revenue Share by Players (2015-2020)
Table 146. Global Specific Antiviral Drugs for COVID-19 Revenue (Million USD) by Regions (2015-2020)
Table 147. Global Specific Antiviral Drugs for COVID-19 Revenue Market Share by Regions (2015-2020)
Table 148. North America Specific Antiviral Drugs for COVID-19 Revenue by Countries (2015-2020)
Table 149. North America Specific Antiviral Drugs for COVID-19 Revenue Market Share by Countries (2015-2020)
Table 150. Europe Specific Antiviral Drugs for COVID-19 Revenue (Million USD) by Countries (2015-2020)
Table 151. Asia-Pacific Specific Antiviral Drugs for COVID-19 Revenue (Million USD) by Countries (2015-2020)
Table 152. South America Specific Antiviral Drugs for COVID-19 Revenue by Countries (2015-2020)
Table 153. South America Specific Antiviral Drugs for COVID-19 Revenue Market Share by Countries (2015-2020)
Table 154. Middle East and Africa Specific Antiviral Drugs for COVID-19 Revenue (Million USD) by Countries (2015-2020)
Table 155. Middle East and Africa Specific Antiviral Drugs for COVID-19 Revenue Market Share by Countries (2015-2020)
Table 156. Global Specific Antiviral Drugs for COVID-19 Revenue (Million USD) by Type (2015-2020)
Table 157. Global Specific Antiviral Drugs for COVID-19 Revenue Share by Type (2015-2020)
Table 158. Global Specific Antiviral Drugs for COVID-19 Revenue Forecast by Type (2021-2025)
Table 159. Global Specific Antiviral Drugs for COVID-19 Revenue by Application (2015-2020)
Table 160. Global Specific Antiviral Drugs for COVID-19 Revenue Share by Application (2015-2020)
Table 161. Global Specific Antiviral Drugs for COVID-19 Revenue Forecast by Application (2021-2025)
Table 162. Global Specific Antiviral Drugs for COVID-19 Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Specific Antiviral Drugs for COVID-19 Picture
Figure 2. Global Specific Antiviral Drugs for COVID-19 Revenue Market Share by Type in 2019
Figure 3. Tablet Picture
Figure 4. Injection Picture
Figure 5. Specific Antiviral Drugs for COVID-19 Revenue Market Share by Application in 2019
Figure 6. Mild Symptom Patient Picture
Figure 7. Critically Ill Patient Picture
Figure 8. Global Specific Antiviral Drugs for COVID-19 Revenue (USD Million) and Growth Rate (2015-2025)
Figure 9. North America Specific Antiviral Drugs for COVID-19 Revenue (Million USD) and Growth Rate (2015-2025)
Figure 10. Europe Specific Antiviral Drugs for COVID-19 Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Asia-Pacific Specific Antiviral Drugs for COVID-19 Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. South America Specific Antiviral Drugs for COVID-19 Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Middle East and Africa Specific Antiviral Drugs for COVID-19 Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Global Specific Antiviral Drugs for COVID-19 Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Specific Antiviral Drugs for COVID-19 Revenue Share by Players in 2019
Figure 16. Global Top 5 Players Specific Antiviral Drugs for COVID-19 Revenue Market Share in 2019
Figure 17. Global Top 10 Players Specific Antiviral Drugs for COVID-19 Revenue Market Share in 2019
Figure 18. Key Players Market Share Trend
Figure 19. Global Specific Antiviral Drugs for COVID-19 Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 20. Global Specific Antiviral Drugs for COVID-19 Revenue Market Share by Regions (2015-2020)
Figure 21. Global Specific Antiviral Drugs for COVID-19 Revenue Market Share by Regions in 2018
Figure 22. North America Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
Figure 23. Europe Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
Figure 24. Asia-Pacific Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
Figure 25. South America Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
Figure 26. Middle East and Africa Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
Figure 27. North America Specific Antiviral Drugs for COVID-19 Revenue Market Share by Countries (2015-2020)
Figure 28. North America Specific Antiviral Drugs for COVID-19 Revenue Market Share by Countries in 2019
Figure 29. USA Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
Figure 30. Canada Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
Figure 31. Mexico Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
Figure 32. Europe Specific Antiviral Drugs for COVID-19 Revenue Market Share by Countries (2015-2020)
Figure 33. Europe Specific Antiviral Drugs for COVID-19 Revenue Market Share by Countries in 2019
Figure 34. Germany Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
Figure 35. UK Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
Figure 36. France Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
Figure 37. Russia Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
Figure 38. Italy Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
Figure 39. Asia-Pacific Specific Antiviral Drugs for COVID-19 Revenue Market Share by Countries (2015-2020)
Figure 40. Asia-Pacific Specific Antiviral Drugs for COVID-19 Revenue Market Share by Countries in 2019
Figure 41. China Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
Figure 42. Japan Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
Figure 43. Korea Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
Figure 44. India Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
Figure 45. Southeast Asia Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
Figure 46. South America Specific Antiviral Drugs for COVID-19 Revenue Market Share by Countries (2015-2020)
Figure 47. South America Specific Antiviral Drugs for COVID-19 Revenue Market Share by Countries in 2019
Figure 48. Brazil Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
Figure 49. Argentina Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
Figure 50. Middle East and Africa Specific Antiviral Drugs for COVID-19 Revenue Market Share by Countries (2015-2020)
Figure 51. Middle East and Africa Specific Antiviral Drugs for COVID-19 Revenue Market Share by Countries in 2019
Figure 52. Saudi Arabia Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
Figure 53. UAE Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
Figure 54. Egypt Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
Figure 55. South Africa Specific Antiviral Drugs for COVID-19 Revenue and Growth Rate (2015-2020)
Figure 56. Global Specific Antiviral Drugs for COVID-19 Revenue Share by Type (2015-2020)
Figure 57. Global Specific Antiviral Drugs for COVID-19 Revenue Share by Type in 2019
Figure 58. Global Specific Antiviral Drugs for COVID-19 Market Share Forecast by Type (2021-2025)
Figure 59. Global Tablet Revenue Growth Rate (2015-2020)
Figure 60. Global Injection Revenue Growth Rate (2015-2020)
Figure 61. Global Specific Antiviral Drugs for COVID-19 Revenue Share by Application (2015-2020)
Figure 62. Global Specific Antiviral Drugs for COVID-19 Revenue Share by Application in 2019
Figure 63. Global Specific Antiviral Drugs for COVID-19 Market Share Forecast by Application (2021-2025)
Figure 64. Global Mild Symptom Patient Revenue Growth Rate (2015-2020)
Figure 65. Global Critically Ill Patient Revenue Growth Rate (2015-2020)
Figure 66. Global Specific Antiviral Drugs for COVID-19 Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 67. Global Specific Antiviral Drugs for COVID-19 Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 68. Global Specific Antiviral Drugs for COVID-19 Revenue Market Share Forecast by Regions (2021-2025)
Figure 69. North America Specific Antiviral Drugs for COVID-19 Revenue Market Forecast (2021-2025)
Figure 70. Europe Specific Antiviral Drugs for COVID-19 Revenue Market Forecast (2021-2025)
Figure 71. Asia-Pacific Specific Antiviral Drugs for COVID-19 Revenue Market Forecast (2021-2025)
Figure 72. South America Specific Antiviral Drugs for COVID-19 Revenue Market Forecast (2021-2025)
Figure 73. Middle East and Africa Specific Antiviral Drugs for COVID-19 Revenue Market Forecast (2021-2025)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
抗ウイルス薬の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The global Antiviral Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.1% in the forecast period of 2020 to 2025 and will expected to reach USD 47600 million by 2025, from USD 42060 million in 2019. The Antiviral Drugs market…- インフルエンザ（インフルエンザ）抗ウイルス薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Influenza (Flu) Antiviral Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…
- 無菌・抗ウイルス包装の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Sterile and Antiviral Packaging market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…
- 肝抗ウイルス薬の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Hepatic Antiviral Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
- 二重特異性抗体療法の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Bi-Specific Antibodies Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opti…